Repaglinide EG 0.5 mg tabl.

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktīvā sastāvdaļa:

Repaglinide 0,5 mg

Pieejams no:

EG SA-NV

ATĶ kods:

A10BX02

SNN (starptautisko nepatentēto nosaukumu):

Repaglinide

Deva:

0,5 mg

Zāļu forma:

Tablet

Kompozīcija:

Repaglinide 0.5 mg

Ievadīšanas:

Oral use

Ārstniecības joma:

Repaglinide

Produktu pārskats:

CTI code: 355661-01 - Pack size: 15 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 355661-02 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 355661-03 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 355661-04 - Pack size: 120 - Commercialisation status: NO - CNK code: 2720951 - Delivery mode: Medical prescription; CTI code: 355661-05 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 355661-06 - Pack size: 270 - Commercialisation status: YES - FMD code: 05400581005725 - CNK code: 2720977 - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: Yes

Autorizācija datums:

2009-12-11